MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $923,968 | -14.7% | 3,298 | -18.6% | 0.00% | -33.3% |
| Q1 2024 | $1,082,581 | +26.1% | 4,054 | +9.2% | 0.00% | 0.0% |
| Q4 2023 | $858,651 | +97.5% | 3,711 | +24.7% | 0.00% | +200.0% |
| Q3 2023 | $434,760 | -36.3% | 2,977 | +0.7% | 0.00% | -50.0% |
| Q2 2023 | $682,605 | +2.2% | 2,955 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $667,669 | -24.7% | 2,756 | -9.7% | 0.00% | -33.3% |
| Q4 2022 | $886,133 | +126.6% | 3,053 | -23.2% | 0.00% | +200.0% |
| Q1 2022 | $391,000 | -7.3% | 3,976 | -20.1% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | +5.8% | 4,979 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $399,000 | -30.8% | 4,999 | -15.6% | 0.00% | -50.0% |
| Q2 2021 | $577,000 | +8.5% | 5,926 | +30.2% | 0.00% | 0.0% |
| Q1 2021 | $532,000 | +10.6% | 4,552 | +5.2% | 0.00% | 0.0% |
| Q4 2020 | $481,000 | +96.3% | 4,326 | +278.8% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | +14.5% | 1,142 | +49.1% | 0.00% | +100.0% |
| Q2 2018 | $214,000 | – | 766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |